Lobbying client · LD-2 disclosures
Hereditary Hemorrhagic Telangiectasia Foundation
Maryland
55 filings from 1 registrant · 2010–2026 · latest filed Jul 17, 2026
Reported on its behalf
$535K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$535K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Defense
DEF
51 filings
$465K on those filings
Health Issues
HCR
48 filings
$510K on those filings
Medical/Disease Research/Clinical Labs
Bills named in the filings
The 15 most-cited of 53 bill references, extracted from the activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Mark Vieth Cavarocchi Ruscio Dennis Associates, L.L.C.59 filingsthrough 2026
- Lyle B Dennis Cavarocchi Ruscio Dennis Associates, L.L.C.5 filingsthrough 2011
The filings
The 20 most recent of 55 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: hereditary-hemorrhagic-telangiectasia-foundation.